E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with A
>
Issuers starting with A, PV only
>
All stories on Adma Biologics, Inc.
>
Stories on Adma Biologics, Inc., PV only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
Adma Biologics, Inc.
12/20/2024
PV
ADMA Biologics reports another partial paydown of debt
8/14/2024
PV
ADMA Biologics repays $30 million of Ares Capital revolver
12/18/2023
PV
ADMA Biologics refinances with $135 million two-tranche facility
5/2/2023
PV
ADMA Biologics amends credit facility via Hayfin for better terms
12/9/2020
PV
New Issue: Adma lifts $85 million Perceptive term loan facility to $100 million
5/3/2019
PV
New Issue: Adma to draw down $27.5 million under $85 million term loan facility
2/12/2019
PV
New Issue: Adma Biologics enters $72.5 million senior secured term loan
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.
